Navigation Links
HeartWare Presentation at the Bank of America Merrill Lynch 2013 Health Care Conference to be Webcast
Date:5/10/2013

FRAMINGHAM, Mass. and SYDNEY, May 10, 2013 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR - ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the Bank of America Merrill Lynch 2013 Health Care Conference at 8:00 a.m. PDT (11:00 am EDT) on Thursday, May 16, 2013.  The conference is being held May 14-16, 2013 at the Encore at Wynn in Las Vegas.

A live webcast of the Company's presentation at the conference will be available via a link provided at www.heartware.com.  A replay of the webcast will be available for 90 days at the site after the presentation.

About HeartWare International
HeartWare International develops and manufactures miniaturized implantable heart pumps, or ventricular assist devices, to treat Class IIIB / IV patients suffering from advanced heart failure. The HeartWare® Ventricular Assist System features the HVAD® pump, a small full-support circulatory assist device designed to be implanted next to the heart, avoiding the abdominal surgery generally required to implant competing devices. The HeartWare System is approved in the United States for the intended use as a bridge to cardiac transplantation in patients who are at risk of death from refractory end-stage left ventricular heart failure, has received CE Marking in the European Union and has been used to treat patients in 30 international countries. The device is also currently the subject of a U.S. clinical trial for destination therapy. For additional information, please visit the Company's
'/>"/>

SOURCE HeartWare International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. HeartWare International Reports $49.2 Million In First Quarter 2013 Revenue; 87% Increase From First Quarter Of 2012
2. HeartWare Schedules First Quarter Conference Call And Webcast
3. HeartWare International, Inc. Announces Pricing of Public Offering of Common Stock
4. HeartWare International, Inc. Announces Public Offering of Common Stock
5. HeartWare Presentation at the Barclays Capital 2013 Global Healthcare Conference To Be Webcast
6. HeartWare Presentation At Raymond James 34th Annual Institutional Investors Conference To Be Webcast
7. HeartWare International Reports Fourth Quarter 2012 Revenue Of $32.7 Million; Full Year 2012 Revenue Of $110.9 Million
8. HeartWare Schedules Fourth Quarter Conference Call and Webcast
9. HeartWare Presentation at Leerink Swann Global Healthcare Conference to be Webcast
10. HeartWare Presentation at the Oppenheimer 23rd Annual Healthcare Conference to be Webcast
11. HeartWare Presentation At The 24th Annual Piper Jaffray Healthcare Conference To Be Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014 AARP Foundation today announced ... older adults suffering from the severe cold weather that has ... committed to helping those in need; so to support these ... contributions up to $250,000, which could mean up to $500,000 ...
(Date:1/15/2014)... THOUSAND OAKS, Calif. , Jan. 15, 2014 ... and Amgen (NASDAQ: AMGN ) announced ... to jointly discover and validate new therapeutic targets ... (IBD), a chronic disorder that affects millions worldwide. ...
(Date:1/15/2014)... BreedIT Corp (OTC: BRDT), through its Israeli ... sophisticated agro-breeding solutions for plant breeders and researchers, today ... of directors appointed chemistry and pharmaceutical industry expert Dr. ... the board. From 1975 to 2012, Dr. ...
Breaking Medicine Technology:AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3
... , LAKE FOREST, Ill., Oct. 27 Hospira, Inc. ... and medication delivery company, today reported results for the ... the quarter were $1.0 billion, and adjusted* diluted earnings ... items as described later in this press release and ...
... today announced $4.5 million in Series A and Convertible Note ... company,s ongoing Phase I/IIa trial of BP-GMAX-CD1 in patients with ... IIb trials. The company anticipates reporting initial results of the ... brings the total raised to date to $8.5 million, including ...
Cached Medicine Technology:Hospira Reports Third-Quarter 2009 Results 2Hospira Reports Third-Quarter 2009 Results 3Hospira Reports Third-Quarter 2009 Results 4Hospira Reports Third-Quarter 2009 Results 5Hospira Reports Third-Quarter 2009 Results 6Hospira Reports Third-Quarter 2009 Results 7Hospira Reports Third-Quarter 2009 Results 8Hospira Reports Third-Quarter 2009 Results 9Hospira Reports Third-Quarter 2009 Results 10Hospira Reports Third-Quarter 2009 Results 11Hospira Reports Third-Quarter 2009 Results 12Hospira Reports Third-Quarter 2009 Results 13Hospira Reports Third-Quarter 2009 Results 14Hospira Reports Third-Quarter 2009 Results 15Hospira Reports Third-Quarter 2009 Results 16Hospira Reports Third-Quarter 2009 Results 17Hospira Reports Third-Quarter 2009 Results 18Hospira Reports Third-Quarter 2009 Results 19Hospira Reports Third-Quarter 2009 Results 20Hospira Reports Third-Quarter 2009 Results 21Hospira Reports Third-Quarter 2009 Results 22Hospira Reports Third-Quarter 2009 Results 23Hospira Reports Third-Quarter 2009 Results 24Hospira Reports Third-Quarter 2009 Results 25Hospira Reports Third-Quarter 2009 Results 26Hospira Reports Third-Quarter 2009 Results 27Hospira Reports Third-Quarter 2009 Results 28Bellicum Pharmaceuticals Announces $4.5 Million in New Funding 2
(Date:4/23/2014)... have shown that proliferation of endogenous neural precursor ... neurons and axons. From the perspective of neural ... Yat-sen University in China observed the effects of ... cell proliferation and expression of basic fibroblast growth ... brain on the infarct side. The researchers found ...
(Date:4/22/2014)... the New Jersey Institute of Technology (NJIT) today ... the launch of the New Jersey Innovation Institute ... model for business innovation through the leveraging of ... U.S. Senator Cory Booker, Panasonic Corp. of North ... Lieutenant Governor Kim Guadagno, New Jersey Secretary of ...
(Date:4/22/2014)... clinics that can provide primary care for low-income ... hospitals and insurance companies while improving patient health, ... admissions suggests that health clinics that avoid costs ... money by lowering hospital admission rates and emergency ... economics, Penn State Altoona. , The researchers ...
(Date:4/22/2014)... women using a newer method of planned sterilization called ... a 10-year period than using the more commonly performed ... and UC Davis has found. , Published online ... study found the higher risk of pregnancy with a ... , "This study provides essential information for women ...
(Date:4/22/2014)... scientists have found a way to block abnormal cholesterol ... atherosclerosis, the main cause of heart attacks and strokes ... condition develops when fat builds inside blood vessels over ... reducing their ability to feed oxygen-rich blood to the ... of experiments, described April 7 in the journal ...
Breaking Medicine News(10 mins):Health News:Government and industry leaders herald launch of NJIT's New Jersey Innovation Institute 2Health News:Clinics not bogged down by red tape can ease health cost burdens 2Health News:Risk of pregnancy greater with newer method of female sterilization 2Health News:Risk of pregnancy greater with newer method of female sterilization 3Health News:Scientists alter fat metabolism in animals to prevent most common type of heart disease 2Health News:Scientists alter fat metabolism in animals to prevent most common type of heart disease 3Health News:Scientists alter fat metabolism in animals to prevent most common type of heart disease 4
... undergoing treatment for breast cancer can experience cognitive declines, ... and attention. Often experienced by patients undergoing chemotherapy, the ... health psychologist at the University of Missouri says "chemo ... associate professor and chair of the Health Psychology Department ...
... , WEDNESDAY, April 11 (HealthDay News) -- ... people in the United States who lived in state-regulated ... federal report. People who live in residential care ... supportive services because they can,t live independently but generally ...
... , WEDNESDAY, April 11 (HealthDay News) -- Being ... a new study that found that genes are at least ... generous. Researchers at the University at Buffalo and the ... different versions of receptor genes for two hormones -- oxytocin ...
... Sciences Discovery Fund (LSDF) today announced nearly $450,000 ... foster commercial translation of new health and health-care ... disease. Dr. Philip Fleckman at the University of ... material for reducing infections associated with kidney dialysis ...
... pacemakers have set the rhythm for many hearts. ... by leaps and bounds: they have become ever-smaller ... toward miniaturized, intelligent systems that will take over ... future implantable sensors will measure glucose levels, blood ...
... Nursing for Women,s Health highlights the importance of a ... contraception is a means of health promotion and women who ... healthy prior to conceiving can minimize their risk of complications ... Disease Control and Prevention (CDC) there were more than four ...
Cached Medicine News:Health News:Stress contributes to cognitive declines in women with breast cancer, researcher says 2Health News: Some Folks Just Can't Help Being Nice, Study Suggests 2Health News:Washington's Life Sciences Discovery Fund awards commercialization grants 2Health News:Power without the cord 2Health News:Power without the cord 3Health News:Timing pregnancy an important health concern for women 2
... iCycler iQ real-time PCR detection system is ... into place directly above the thermal cycler. ... wavelengths available, facilitating the greatest array of ... of the iCycler iQ system, the iCycler ...
Chemically Resistant Sealing Mat for 96ch, 1.1ml or 2.0ml, Deep Well, Round Available Sterile...
Sealing Mat for 384-well, Square Well Plates Available Sterile...
Silicone Compression Mat, Bulk...
Medicine Products: